SCHEMBL7224642

SCHEMBL7224642

CCCc1n[nH]c2ccc(O)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.43
MAP2K4 P45985 2/20 0.43
MAPKAPK2 P49137 2/20 0.43
MAPKAPK3 Q16644 2/20 0.43
MAPK6 Q16659 2/20 0.43
MAPKAPK5 Q8IW41 1/20 0.43
HTR1D P28221 4/20 0.41
HTR2C P28335 6/20 0.41
HTR2A P28223 4/20 0.41
HTR2B P41595 3/20 0.41
HSP90AB1 P08238 2/20 0.40
PDPK1 O15530 1/20 0.40
HSP90AA1 P07900 1/20 0.39
PARP1 P09874 2/20 0.39
CYP2D6 P10635 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
HTR7 P34969 2/20 0.39
HTR3A P46098 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7134511 0.89 CYP3A4 (0.44) MAPK1MAP2K4MAPKAPK2MAPKAPK3MAPK6
SCHEMBL25435255 0.83 HTR2C (0.41) MAPK1MAP2K4MAPKAPK2MAPKAPK3MAPK6
SCHEMBL5988413 0.83 HTR2C (0.51) MAPK1MAP2K4MAPKAPK2MAPKAPK3MAPK6
SCHEMBL5989507 0.83 HTR2C (0.58) MAPK1MAP2K4MAPKAPK2MAPKAPK3MAPK6
SCHEMBL20001489 0.81 MAP2K4 (0.48) MAPK1MAP2K4MAPKAPK2MAPKAPK3MAPK6
SCHEMBL12881956 0.80 HTR6 (0.44) HTR2AHTR2BHTR7HTR6GSK3B
SCHEMBL1144803 0.80 PDPK1 (0.54) HTR2CHTR2AHTR2BPDPK1CYP1A2
SCHEMBL7133357 0.79 HTR2A (0.43) MAPK1MAP2K4MAPKAPK2MAPKAPK3MAPK6
SCHEMBL1144988 0.78 KDM4E (0.50) MAPK1MAP2K4MAPKAPK3MAPK6HTR7
SCHEMBL6227298 0.78 HTR2A (0.42) MAPK1MAP2K4MAPKAPK2MAPKAPK3MAPK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6608049-B2 Indazoles BAYER AKTIENGESELLSCHAFT (DE) 2003-08-19 US disclosed
US-20020193610-A1 Indazoles BAYER AKTIENGESELLSCHAFT (DE) 2002-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193610-A1 Indazoles CYP3A43, CYP3A5, CYP3A4 MAPK1 4226/4885MAP2K4 3882/4885MAPKAPK2 3492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.